“Get the Scoop: Our Fun and Quirky Take on Buying Back Our Own Shares!”

Feeling Like a Shareholder Pro With Endeavour Mining plc’s Latest Move What’s the Scoop on Endeavour’s Recent Share Transaction? London, 28 January 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) proudly announces its recent acquisition of 2,000 of its own ordinary shares through a transaction with Stifel Nicolaus Europe Limited. The purchase, made on…

Read More

“Get Ready to Cash In: A Sneak Peek at IBM’s Earnings – Plus, a 7% Free Cash Flow Yield and Rising EPS Projections!”

IBM Q4 ’24 Earnings Report: What to Expect Get Ready for the Big Day Mark your calendars because IBM is set to announce their fourth-quarter earnings for 2024 on Wednesday, January 29th. Investors are eagerly awaiting this information to see how the tech giant has performed in the past quarter. Analyst Predictions According to sell-side…

Read More

“Revolutionizing Breast Cancer Treatment: Genentech’s Itovebi Shows Promising Results for HR-Positive Advanced Breast Cancer Patients”

Exciting News in Cancer Treatment Research Positive Results in Phase III Clinical Trial for INAVO120 Study In a recent announcement, Genentech disclosed positive topline results from the Phase III INAVO120 study, evaluating the efficacy of ItovebiTM (inavolisib) in combination with palbociclib (Ibrance®) and fulvestrant for individuals with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant, locally advanced or…

Read More

“Bitfarms Announces Exciting Partnership with HIVE Digital Technologies for Sale of Yguazu Paraguay Site”

Bitfarms to Reinvest Capital in US Growth Opportunities Accretive transaction values the completed site at ~$85 million and significantly reduces anticipated 2025 capital requirements Rebalances YE 2025 proforma energy portfolio to ~80% North American & 20% international Bitfarms Ltd. has recently announced its plans to reinvest capital in US growth opportunities, with an accretive transaction…

Read More